Work

Psychopharmacotherapy of Premenstrual Dysphoric Disorder—New Vistas

Year: 2025
Type: article
Abstract: Nearly forty percent of women with PMDD remain impaired and resistant to first-line agents. This reflects complexity and heterogeneity of etiopathogenesis at the core of PMDD. Some agents, in the pipeline, sound promising that might usher in a new sparkle in the psychopharmacology of PMDD.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W4285028396
FWCI: 0.846
Cites: 6
Cited by: 1
Related to: 10